To view this email as a web page, click here.
 
Major PBM’s formulary exclusions cause concerns
Pharmaceutical industry observers are concerned about some of the drugs that were slashed from Express Scripts’ 2019 National Preferred Formulary.
Read more
 
First drug approved under streamlined generic approval process
The first medication approved by FDA as part of an expedited generic drug program is one that has been in short supply in U.S. hospitals.
Read more
 
New targeted melanoma combo drug available
A combination melanoma treatment approved by FDA is now available through select specialty pharmacies.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.